Cargando…
Characterization of Promiscuous Binding of Phosphor Ligands to Breast-Cancer-Gene 1 (BRCA1) C-Terminal (BRCT): Molecular Dynamics, Free Energy, Entropy and Inhibitor Design
Inhibition of the protein-protein interaction (PPI) mediated by breast-cancer-gene 1 C-terminal (BRCT) is an attractive strategy to sensitize breast and ovarian cancers to chemotherapeutic agents that induce DNA damage. Such inhibitors could also be used for studies to understand the role of this PP...
Autores principales: | You, Wanli, Huang, Yu-ming M., Kizhake, Smitha, Natarajan, Amarnath, Chang, Chia-en A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999267/ https://www.ncbi.nlm.nih.gov/pubmed/27560145 http://dx.doi.org/10.1371/journal.pcbi.1005057 |
Ejemplares similares
-
Structure of BRCA1-BRCT/Abraxas Complex Reveals Phosphorylation-Dependent BRCT Dimerization at DNA Damage Sites
por: Wu, Qian, et al.
Publicado: (2016) -
Mutations in the BRCT binding site of BRCA1 result in hyper-recombination
por: Dever, Seth M., et al.
Publicado: (2011) -
Impact of BRCA1 BRCT Domain Missense Substitutions on Phosphopeptide Recognition
por: Coquelle, Nicolas, et al.
Publicado: (2011) -
Targeting Phosphopeptide Recognition by the Human BRCA1 Tandem BRCT Domain to Interrupt BRCA1-Dependent Signaling
por: Periasamy, Jayaprakash, et al.
Publicado: (2018) -
Effects on human transcriptome of mutated BRCA1 BRCT domain: A microarray study
por: Iofrida, Caterina, et al.
Publicado: (2012)